|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.03 USD | +0.91% |
|
-0.85% | +79.35% |
| 10/07 | Immucell Corporation Reports Preliminary Unaudited Sales Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 15/05 | ImmuCell Corporation, Q1 2026 Earnings Call, May 15, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUCELL CORPORATION | Other Pharmaceuticals | +0.91% | -0.85% | +79.35% | +63.17% | +8.99% | 9.89Cr |  | | |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
